BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Determining Value is as Critical to Commercial Success as Clinical Data

  The shifting focus from drug pricing to drug value is having a significant effect on innovation, performance and even investments.

  March 2, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  While Life Sciences Industry Remains Strong, Some Big Names Face Layoffs

  The biopharma industry remained strong, as demand for COVID-related products skyrocketed. However, some companies are facing layoffs. Here’s a brief overview.

  March 2, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Agilent Adds Liquid Biopsy Assay to Diagnostic Tool Bag with $550 Million Buy

  If Resolution hits specified milestones, it’ll scoop up an extra $145 million from Agilent.

  March 2, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Policy

  Merck’s Keytruda Pulled for SCLC as FDA Re-Evaluates Past Accelerated Approvals

  The company notes that this decision has no effect on other indications for Keytruda.

  March 2, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  Last-Minute FDA Advisory Panel Puts a Kink in Approval Hopes for Anemia Drug Roxadustat

  The U.S. FDA has decided to put together an advisory committee meeting of outside experts to review a New Drug Application for roxadustat, FibroGen and its partner AstraZeneca’s investigational anemia therapy.

  March 2, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  BioMidwest

  AbbVie to Fund Mitokinin’s Parkinson Research with Option to Buy

  AbbVie bought an exclusive right to acquire San Francisco-based Mitokinin after the company completes its Investigational New Drug-enabling studies on its lead program, PINK1, for Parkinson’s disease.

  March 2, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Money on the Move: February 24 – March 2

  With the overflow of investments into life sciences, who has time to keep up? Find your weekly snapshot of where the cash is headed in this week’s Money on the Move.

  March 2, 2021

   · 

  8 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Novavax Counting on COVID-19 Vaccine U.S. EUA by May

  Novavax Chief Executive Officer Stanley Erck believes the U.S. Food and Drug Administration could grant Emergency Use Authorization for its COVID-19 vaccine by May.

  March 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  2021 Biopharma Update on the Novel Coronavirus: March 2

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 2, 2021.

  March 2, 2021

   · 

  5 min read

   · 

  BioSpace Editorial Staff
• 

  Genetown

  eGenesis Snags $125 Million for Cross-Species Organ Transplantation Tech

  Xenotransplantation company eGenesis raised $125 million in a Series C financing round to drive the company’s lead programs in kidney and islet cell transplant into the clinic.

  March 2, 2021

   · 

  2 min read

   · 

  Alex Keown